[Bacterial infections in liver cirrhosis]
- PMID: 17344166
- DOI: 10.1556/OH.2007.27882
[Bacterial infections in liver cirrhosis]
Abstract
Bacterial infections are well described complications of cirrhosis that greatly increase mortality rates. Two factors play important roles in the development of bacterial infections in these patients: the severity of liver disease and gastrointestinal haemorrhage. The most common infections are spontaneous bacterial peritonitis, urinary tract infections, pneumonia and sepsis. Gram-negative and gram-positive bacteria are equal causative organisms. For primary prophylaxis, short-term antibiotic treatment (oral norfloxacin or ciprofloxacin) is indicated in cirrhotic patients (with or without ascites) admitted with gastrointestinal haemorrhage (variceal or non-variceal). Administration of norfloxacin is advisable for hospitalized patients with low ascitic protein even without gastrointestinal haemorrhage. The first choice in empirical treatment of spontaneous bacterial peritonitis is the iv. III. generation cephalosporin; which can be switched for a targeted antibiotic regime based on the result of the culture. The duration of therapy is 5-8 days. Amoxicillin/clavulanic acid and fluoroquinolones--patients not on prior quinolone prophylaxis--were shown to be as effective and safe as cefotaxime. In patients with evidence of improvement, iv. antibiotics can be switched safely to oral antibiotics after 2 days. In case of renal dysfunction, iv albumin should also be administered. Long-term antibiotic prophylaxis is recommended in patients who have recovered from an episode of spontaneous bacterial peritonitis (secondary prevention). For "selective intestinal decontamination", poorly absorbed oral norfloxacin is the preferred schedule. Oral ciprofloxacin or levofloxacin (added gram positive spectrum) all the more are reasonable alternatives. Trimethoprim/sulfamethoxazole is only for patients who are intolerant to quinolones. Prophylaxis is indefinite until disappearance of ascites, transplant or death. Long-term prophylaxis is currently not recommended for patients without previous spontaneous bacterial peritonitis episode, not even when refractory ascites or low ascites protein content is present.
Similar articles
-
Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients.Hepatology. 1999 Apr;29(4):1064-9. doi: 10.1002/hep.510290406. Hepatology. 1999. PMID: 10094947
-
Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage.Gastroenterology. 2006 Oct;131(4):1049-56; quiz 1285. doi: 10.1053/j.gastro.2006.07.010. Gastroenterology. 2006. PMID: 17030175 Clinical Trial.
-
Parenteral antibiotic prophylaxis of bacterial infections does not improve cost-efficacy of oral norfloxacin in cirrhotic patients with gastrointestinal bleeding.Am J Gastroenterol. 1998 Dec;93(12):2457-62. doi: 10.1111/j.1572-0241.1998.00704.x. Am J Gastroenterol. 1998. PMID: 9860409 Clinical Trial.
-
[Spontaneous bacterial peritonitis].Orv Hetil. 2017 Jan;158(2):50-57. doi: 10.1556/650.2017.30637. Orv Hetil. 2017. PMID: 28088889 Review. Hungarian.
-
Bacterial infections in cirrhosis.Can J Gastroenterol. 2004 Jun;18(6):405-6. doi: 10.1155/2004/769615. Can J Gastroenterol. 2004. PMID: 15190398 Review.
Cited by
-
Liver cirrhosis and complications from the perspective of dysbiosis.Front Med (Lausanne). 2024 Jan 16;10:1320015. doi: 10.3389/fmed.2023.1320015. eCollection 2023. Front Med (Lausanne). 2024. PMID: 38293307 Free PMC article. Review.
-
Immunosuppressive treatment in autoimmune decompensated cirrhosis, when to say enough: A retrospective analysis.Medicine (Baltimore). 2025 Feb 7;104(6):e41378. doi: 10.1097/MD.0000000000041378. Medicine (Baltimore). 2025. PMID: 39928808 Free PMC article.
-
Assessment of the fecal lactobacilli population in patients with hepatitis B virus-related decompensated cirrhosis and hepatitis B cirrhosis treated with liver transplant.Microb Ecol. 2012 May;63(4):929-37. doi: 10.1007/s00248-011-9945-1. Epub 2011 Oct 1. Microb Ecol. 2012. PMID: 21965156
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical